Respond to Safety Information in a Scientific Email
Handle a potential safety report raised by email while separating reporting responsibilities from scientific discussion.
A scientific email can change course when a clinician includes information about a possible adverse event. A medical science liaison should follow the applicable reporting process promptly and keep scientific discussion separate from any assessment of causality or patient care. Fast, disciplined handling matters more than composing a polished scientific reply first.
Preserve the information needed for the reporting pathway and follow internal process requirements. Acknowledge receipt in appropriate language, then explain that questions about an individual’s care belong with the treating clinician. Do not decide whether the product caused the event, advise on management, or minimize the report because the email also contains a literature question.
In a fictional email exchange, a pharmacist writes, “A patient had a serious reaction after treatment. Was it caused by the product, and can you send the new safety paper?” The liaison responds, “Thank you for raising this information. I will ensure it is handled through the appropriate safety reporting process. I cannot assess causality or provide guidance for an individual patient; for the literature question, I can arrange a separate scientific information follow-up.” The pharmacist supplies the requested reporting details through the proper channel.
Practice sorting a mixed email into reporting and scientific follow-up actions. A reviewer should see prompt escalation, no causal language, and a separate owner for the literature request. The record should describe the required process steps without offering an opinion about the event or an individual patient’s treatment.
Practice these next
Use approved safety information and the appropriate reporting pathway without assigning causality.
Prepare for a scientific advisory conversation with a clear scope and balanced evidence plan.
Provide dated references for a committee discussion without directing a protocol change.
Clarify a medical director’s request and coordinate balanced materials before a committee meeting.
Clarify an early study idea and explain the submission path without promising support or funding.
Capture a researcher's early scientific question clearly while avoiding a commitment about study support or protocol direction.